Precil Diego Miranda de Menezes Neves
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Precil Diego Miranda de Menezes Neves has a total of 340 co-authors. Here are the top co-authors by number of shared publications:
- Viktoria Woronik
Department of Nephrology, Faculty of Medicine, University of São Paulo, São Paulo 00458-020, Brazil
8 shared publications - Luis Gustavo Modelli de Andrade
Sao Paulo State University
6 shared publications - Luiz Fernando Onuchic
Division of Molecular Medicine, University of São Paulo School of Medicine, São Paulo, Brazil
6 shared publications Américo Lourenço Cuvello-Neto
Nephrology and Dialysis Center, Oswaldo Cruz German Hospital, São Paulo, Brazil
5 shared publications- Cristiane Bitencourt Dias
Universidade de São Paulo, Brazil
5 shared publications - Irene de Lourdes Noronha
Affiliations Clinical Nephrology Department of the Brazilian Society of Nephrology, São Paulo, Brazil, Renal Division, Hospital das Clínicas, University of São Paulo Medical School, São Paulo, Brazil
5 shared publications
Latest Publications
- Open Access
- 1 February 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (3) , 437
JAK3 Staining and CD68+ Macrophage Counts Are Increased in Patients with IgA Nephropathy
Background/Objectives: IgA nephropathy (IgAN) is the most common primary glomerulopathy worldwide; it is characterized by a complex pathophysiology involving several inflammatory pathways. The Janus kinase/signal transducer and activator of transcription (JAK/STAT) pathway may be critical in this process. This study aimed to investigate the role of this pathway in IgAN and examine related tissue inflammatory markers. Methods: We analyzed 63 biopsy-confirmed patients with IgAN and performed immunohistochemical analysis on renal samples. A panel of antibodies targeting the JAK/STAT pathway, including JAK2, JAK3, p-STAT, STAT3, and MAPK/ERK, was used for this analysis. Six kidney tumor border samples were used as controls. Additionally, CD68 staining was used to evaluate tissue inflammation in the kidney biopsies. Results: Patients with IgAN showed a significantly higher cellular density of JAK3 staining at the glomerular level compared to controls, indicating JAK3 activation (p < 0.0002). Nevertheless, the correlation between JAK3 positivity in glomeruli and clinical parameters such as the initial and final estimated glomerular filtration rate (eGFR) and proteinuria was not statistically significant. Identical results were obtained with CD68+ macrophage counts in the glomerular compartment, which did not show any correlation with clinical parameters, while CD68+ tubulointerstitial staining demonstrated a significant correlation with both initial (p = 0.002) and final eGFRs (p = 0.0014), proteinuria (p = 0.010), and interstitial fibrosis (p < 0.001), as well as with renal disease progression (p = 0.005). Conclusions: Activation of the JAK/STAT pathway was observed in patients with IgAN relative to controls, notwithstanding the inability to assess the full pathway due to technical limitations. Macrophage CD68 staining in the tubulointerstitial area increased and was associated with clinical and laboratory parameters such as eGFR and proteinuria. Additionally, MEST-C histological parameters, such as segmental glomerulosclerosis (S0/S1), tubular atrophy/interstitial fibrosis (T0/T1/T2), and crescents (C0/C1/C2), were associated with a higher number of CD68+ cells.
- 1 February 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (3) , 437
Open AccessJAK3 Staining and CD68+ Macrophage Counts Are Increased in Patients with IgA Nephropathy
Background/Objectives: IgA nephropathy (IgAN) is the most common primary glomerulopathy worldwide; it is characterized by a complex pathophysiology involving several inflammatory pathways. The Janus kinase/signal transducer and activator of transcription (JAK/STAT) pathway may be critical in this process. This study aimed to investigate the role of this pathway in IgAN and examine related tissue inflammatory markers. Methods: We analyzed 63 biopsy-confirmed patients with IgAN and performed immunohistochemical analysis on renal samples. A panel of antibodies targeting the JAK/STAT pathway, including JAK2, JAK3, p-STAT, STAT3, and MAPK/ERK, was used for this analysis. Six kidney tumor border samples were used as controls. Additionally, CD68 staining was used to evaluate tissue inflammation in the kidney biopsies. Results: Patients with IgAN showed a significantly higher cellular density of JAK3 staining at the glomerular level compared to controls, indicating JAK3 activation (p < 0.0002). Nevertheless, the correlation between JAK3 positivity in glomeruli and clinical parameters such as the initial and final estimated glomerular filtration rate (eGFR) and proteinuria was not statistically significant. Identical results were obtained with CD68+ macrophage counts in the glomerular compartment, which did not show any correlation with clinical parameters, while CD68+ tubulointerstitial staining demonstrated a significant correlation with both initial (p = 0.002) and final eGFRs (p = 0.0014), proteinuria (p = 0.010), and interstitial fibrosis (p < 0.001), as well as with renal disease progression (p = 0.005). Conclusions: Activation of the JAK/STAT pathway was observed in patients with IgAN relative to controls, notwithstanding the inability to assess the full pathway due to technical limitations. Macrophage CD68 staining in the tubulointerstitial area increased and was associated with clinical and laboratory parameters such as eGFR and proteinuria. Additionally, MEST-C histological parameters, such as segmental glomerulosclerosis (S0/S1), tubular atrophy/interstitial fibrosis (T0/T1/T2), and crescents (C0/C1/C2), were associated with a higher number of CD68+ cells.
- Open Access
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Nephrology
- Vol. 48 (4)
Registro brasileiro de biópsias renais: resultados do registro nacional prospectivo de 2022
RESUMO Introdução: A biópsia renal é fundamental para o diagnóstico etiológico e o manejo das doenças renais. O Registro Brasileiro de Biópsias Renais (RBBR), criado pela Sociedade Brasileira de Nefrologia, visa caracterizar o perfil clínico e histopatológico das biópsias renais realizadas no Brasil. O objetivo deste artigo é apresentar os dados do RBBR de 2022. Métodos: Análise dos dados de pacientes adultos submetidos à biópsia de rim nativo e incluídos prospectivamente no RBBR entre janeiro e dezembro de 2022. Foram avaliados dados demográficos, clínicos, laboratoriais e histopatológicos. Resultados: Foram incluídas 1.142 biópsias renais provenientes de centros de todas as regiões do país. Houve discreto predomínio do sexo feminino (54,8%), com idade média de 44,8 ± 16,4 anos. As principais indicações para biópsia foram disfunção renal (51,8%) e síndrome nefrótica (39,4%). Hipertensão arterial e diabetes mellitus estavam presentes em 47,8% e 15,1% dos pacientes, respectivamente. No momento da biópsia, 67,1% apresentavam taxa de filtração glomerular estimada < 60 mL/min/1,73 m2. As doenças glomerulares corresponderam a 72,5% dos diagnósticos histológicos, sendo a nefrite lúpica (23,1%), a nefropatia por IgA (15,0%) e a glomeruloesclerose segmentar e focal (11,2%) as mais frequentes. Conclusão: Os dados de 2022 do RBBR confirmam a predominância das doenças glomerulares entre as biópsias renais no Brasil e reforçam a relevância do registro como ferramenta para a compreensão da epidemiologia das doenças renais no país. Entre os pacientes diabéticos submetidos à biópsia, apenas metade apresentou evidências histológicas de nefropatia diabética, o que ressalta a importância da biópsia renal em casos selecionados.
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Nephrology
- Vol. 48 (4)
Open AccessRegistro brasileiro de biópsias renais: resultados do registro nacional prospectivo de 2022
RESUMO Introdução: A biópsia renal é fundamental para o diagnóstico etiológico e o manejo das doenças renais. O Registro Brasileiro de Biópsias Renais (RBBR), criado pela Sociedade Brasileira de Nefrologia, visa caracterizar o perfil clínico e histopatológico das biópsias renais realizadas no Brasil. O objetivo deste artigo é apresentar os dados do RBBR de 2022. Métodos: Análise dos dados de pacientes adultos submetidos à biópsia de rim nativo e incluídos prospectivamente no RBBR entre janeiro e dezembro de 2022. Foram avaliados dados demográficos, clínicos, laboratoriais e histopatológicos. Resultados: Foram incluídas 1.142 biópsias renais provenientes de centros de todas as regiões do país. Houve discreto predomínio do sexo feminino (54,8%), com idade média de 44,8 ± 16,4 anos. As principais indicações para biópsia foram disfunção renal (51,8%) e síndrome nefrótica (39,4%). Hipertensão arterial e diabetes mellitus estavam presentes em 47,8% e 15,1% dos pacientes, respectivamente. No momento da biópsia, 67,1% apresentavam taxa de filtração glomerular estimada < 60 mL/min/1,73 m2. As doenças glomerulares corresponderam a 72,5% dos diagnósticos histológicos, sendo a nefrite lúpica (23,1%), a nefropatia por IgA (15,0%) e a glomeruloesclerose segmentar e focal (11,2%) as mais frequentes. Conclusão: Os dados de 2022 do RBBR confirmam a predominância das doenças glomerulares entre as biópsias renais no Brasil e reforçam a relevância do registro como ferramenta para a compreensão da epidemiologia das doenças renais no país. Entre os pacientes diabéticos submetidos à biópsia, apenas metade apresentou evidências histológicas de nefropatia diabética, o que ressalta a importância da biópsia renal em casos selecionados.
- Open Access
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Nephrology
- Vol. 48 (4)
The Brazilian registry of kidney biopsies: results from the 2022 national prospective registry
Introduction: Kidney biopsy plays a central role in the etiological diagnosis and management of kidney diseases. The Brazilian Registry of Kidney Biopsies (BRKB) was established by the Brazilian Society of Nephrology to characterize biopsy-proven kidney diseases nationwide. The aim of this manuscript is to present the BRKB data for 2022. Methods: We analyzed data from adult patients who underwent native kidney biopsy and were prospectively included in the BRKB between January and December 2022. Demographic, clinical, laboratory, and histopathological variables were evaluated. Results: A total of 1,142 kidney biopsies from centers across all Brazilian regions were included. Female patients accounted for 54.8% of cases, and the mean age was 44.8 ± 16.4 years. The main indications for biopsy were kidney dysfunction (51.8%) and nephrotic syndrome (39.4%). Hypertension and diabetes mellitus were present in 47.8% and 15.1% of patients, respectively. At the time of biopsy, 67.1% had an estimated glomerular filtration rate < 60 mL/min/1.73 m2. Glomerular diseases were the most frequent histological diagnoses (72.5%), with lupus nephritis (23.1%), IgA nephropathy (15.0%), and focal segmental glomerulosclerosis (11.2%) being the most common. Conclusion: The 2022 BRKB data provide a contemporary overview of biopsy-proven kidney diseases in Brazil and highlight the predominance of glomerular disorders. Among diabetic patients undergoing biopsy, only half showed histological evidence of diabetic nephropathy, emphasizing the value of kidney biopsy in selected cases.
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Nephrology
- Vol. 48 (4)
Open AccessThe Brazilian registry of kidney biopsies: results from the 2022 national prospective registry
Introduction: Kidney biopsy plays a central role in the etiological diagnosis and management of kidney diseases. The Brazilian Registry of Kidney Biopsies (BRKB) was established by the Brazilian Society of Nephrology to characterize biopsy-proven kidney diseases nationwide. The aim of this manuscript is to present the BRKB data for 2022. Methods: We analyzed data from adult patients who underwent native kidney biopsy and were prospectively included in the BRKB between January and December 2022. Demographic, clinical, laboratory, and histopathological variables were evaluated. Results: A total of 1,142 kidney biopsies from centers across all Brazilian regions were included. Female patients accounted for 54.8% of cases, and the mean age was 44.8 ± 16.4 years. The main indications for biopsy were kidney dysfunction (51.8%) and nephrotic syndrome (39.4%). Hypertension and diabetes mellitus were present in 47.8% and 15.1% of patients, respectively. At the time of biopsy, 67.1% had an estimated glomerular filtration rate < 60 mL/min/1.73 m2. Glomerular diseases were the most frequent histological diagnoses (72.5%), with lupus nephritis (23.1%), IgA nephropathy (15.0%), and focal segmental glomerulosclerosis (11.2%) being the most common. Conclusion: The 2022 BRKB data provide a contemporary overview of biopsy-proven kidney diseases in Brazil and highlight the predominance of glomerular disorders. Among diabetic patients undergoing biopsy, only half showed histological evidence of diabetic nephropathy, emphasizing the value of kidney biopsy in selected cases.
- Open Access
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Nephrology
- Vol. 48 (4)
Epidemiology of glomerular diseases in Northeastern Brazil from 2008–2024
Introduction: Glomerulopathies are the third leading cause of dialysis-dependent chronic kidney disease (CKD) in Brazil and are most commonly diagnosed by kidney biopsy; however, data regarding the prevalence and epidemiological characteristics of glomerulopathies are scarce. The present article reports the results of an epidemiological survey of glomerular diseases in Northeast Brazil. Methods: This retrospective study, based on kidney biopsy data from all states in Northeast Brazil (2008–2024), was conducted at a reference center for kidney pathology. Demographic data (age, sex, and ethnicity), clinical history, indications for kidney biopsy, and histopathological diagnoses were collected. Frequencies are presented as percentages, along with maps and charts. Results: Data from 2,661 patients (median age, 31 years [interquartile range, 19–45 years]) were included in the study, with a slight female predominance (n = 1,533 [57.6%]). The indication for biopsy was identified in 85.9% of cases, with nephrotic syndrome being the most common (n = 1,075 [40.39%]). Lupus nephritis (LN) was the most frequent etiology (n = 876 [32.9%]), followed by focal segmental glomerulosclerosis (FSGS; n = 455 [17.1%]). The most common diagnosis among older adults was membranous nephropathy (n = 43 [18.8%]), whereas the most prevalent diagnosis among children was FSGS (n = 105 [24.5%]). Conclusion: The profile of glomerulopathies reflects not only local biopsy indications but also the heterogeneity of the population of Northeast Brazil and its particular ethnic and socioeconomic characteristics. Glomerulopathies, such as LN, accounted for the majority of cases, indicating the influence of ancestral factors in this region.
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Nephrology
- Vol. 48 (4)
Open AccessEpidemiology of glomerular diseases in Northeastern Brazil from 2008–2024
Introduction: Glomerulopathies are the third leading cause of dialysis-dependent chronic kidney disease (CKD) in Brazil and are most commonly diagnosed by kidney biopsy; however, data regarding the prevalence and epidemiological characteristics of glomerulopathies are scarce. The present article reports the results of an epidemiological survey of glomerular diseases in Northeast Brazil. Methods: This retrospective study, based on kidney biopsy data from all states in Northeast Brazil (2008–2024), was conducted at a reference center for kidney pathology. Demographic data (age, sex, and ethnicity), clinical history, indications for kidney biopsy, and histopathological diagnoses were collected. Frequencies are presented as percentages, along with maps and charts. Results: Data from 2,661 patients (median age, 31 years [interquartile range, 19–45 years]) were included in the study, with a slight female predominance (n = 1,533 [57.6%]). The indication for biopsy was identified in 85.9% of cases, with nephrotic syndrome being the most common (n = 1,075 [40.39%]). Lupus nephritis (LN) was the most frequent etiology (n = 876 [32.9%]), followed by focal segmental glomerulosclerosis (FSGS; n = 455 [17.1%]). The most common diagnosis among older adults was membranous nephropathy (n = 43 [18.8%]), whereas the most prevalent diagnosis among children was FSGS (n = 105 [24.5%]). Conclusion: The profile of glomerulopathies reflects not only local biopsy indications but also the heterogeneity of the population of Northeast Brazil and its particular ethnic and socioeconomic characteristics. Glomerulopathies, such as LN, accounted for the majority of cases, indicating the influence of ancestral factors in this region.
- Open Access
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Nephrology
- Vol. 48 (4)
Epidemiologia das doenças glomerulares no Nordeste do Brasil de 2008 a 2024
RESUMO Introdução: As glomerulopatias são a terceira principal causa de doença renal crônica (DRC) dependente de diálise no Brasil e são diagnosticadas mais comumente por meio de biópsia renal; no entanto, os dados referentes à prevalência e às características epidemiológicas das glomerulopatias são escassos. O presente artigo relata os resultados de um levantamento epidemiológico de doenças glomerulares no Nordeste do Brasil. Métodos: Este estudo retrospectivo, baseado em dados de biópsias renais de todos os estados do Nordeste do Brasil (2008–2024), foi conduzido em um centro de referência em patologia renal. Foram coletados dados demográficos (idade, sexo e etnia), histórico clínico, indicações para biópsia renal e diagnósticos histopatológicos. As frequências são apresentadas em porcentagens, com a geração de mapas e gráficos. Resultados: Foram incluídos no estudo dados de 2.661 pacientes (idade mediana de 31 anos; intervalo interquartil [IIQ],19–45), com leve predominância do sexo feminino (n = 1.533 [57,60%]). A indicação para biópsia foi identificada em 85,9% dos casos, sendo a síndrome nefrótica a mais comum (n = 1.075 [40,39%]). A nefrite lúpica (NL) foi a etiologia mais frequente (n = 876 [32,9%]), seguida pela glomeruloesclerose segmentar focal (GESF; n = 455 [17,1%]). O diagnóstico mais comum entre os idosos foi nefropatia membranosa (n = 43 [18,8%]), enquanto o diagnóstico mais prevalente entre as crianças foi GESF (n = 105 [24,5%]). Conclusão: O perfil de glomerulopatias reflete não apenas as indicações locais para biópsia, mas também a heterogeneidade da população do Nordeste do Brasil e suas características étnicas e socioeconômicas particulares. Glomerulopatias, como a NL, representaram a maioria dos casos, indicando a influência de fatores ancestrais nessa região.
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Nephrology
- Vol. 48 (4)
Open AccessEpidemiologia das doenças glomerulares no Nordeste do Brasil de 2008 a 2024
RESUMO Introdução: As glomerulopatias são a terceira principal causa de doença renal crônica (DRC) dependente de diálise no Brasil e são diagnosticadas mais comumente por meio de biópsia renal; no entanto, os dados referentes à prevalência e às características epidemiológicas das glomerulopatias são escassos. O presente artigo relata os resultados de um levantamento epidemiológico de doenças glomerulares no Nordeste do Brasil. Métodos: Este estudo retrospectivo, baseado em dados de biópsias renais de todos os estados do Nordeste do Brasil (2008–2024), foi conduzido em um centro de referência em patologia renal. Foram coletados dados demográficos (idade, sexo e etnia), histórico clínico, indicações para biópsia renal e diagnósticos histopatológicos. As frequências são apresentadas em porcentagens, com a geração de mapas e gráficos. Resultados: Foram incluídos no estudo dados de 2.661 pacientes (idade mediana de 31 anos; intervalo interquartil [IIQ],19–45), com leve predominância do sexo feminino (n = 1.533 [57,60%]). A indicação para biópsia foi identificada em 85,9% dos casos, sendo a síndrome nefrótica a mais comum (n = 1.075 [40,39%]). A nefrite lúpica (NL) foi a etiologia mais frequente (n = 876 [32,9%]), seguida pela glomeruloesclerose segmentar focal (GESF; n = 455 [17,1%]). O diagnóstico mais comum entre os idosos foi nefropatia membranosa (n = 43 [18,8%]), enquanto o diagnóstico mais prevalente entre as crianças foi GESF (n = 105 [24,5%]). Conclusão: O perfil de glomerulopatias reflete não apenas as indicações locais para biópsia, mas também a heterogeneidade da população do Nordeste do Brasil e suas características étnicas e socioeconômicas particulares. Glomerulopatias, como a NL, representaram a maioria dos casos, indicando a influência de fatores ancestrais nessa região.
- Open Access
- 1 January 2026
- Published by MDPI AG in Preprints.org
JAK3 Staining and CD68+ Macrophage Counts are Increased in Patients with IgA Nephropathy
Background/Objectives: IgA nephropathy (IgAN) is the most common primary glomerulopathy worldwide; it is characterized by a complex pathophysiology involving several inflammatory pathways. The Janus kinase/signal transducer and activator of transcription (JAK/STAT) pathway may be critical in this process. This study aimed to investigate the role of this pathway in IgAN and examine related tissue inflammatory markers. Methods: We analyzed 63 biopsy-confirmed patients with IgAN and performed immunohistochemical analysis on renal samples. A panel of antibodies targeting the JAK/STAT pathway, including JAK2, JAK3, p-STAT, STAT3, and MAPK/ERK, was used for this analysis. Six kidney tumor border samples were used as controls. Additionally, CD68 staining was used to evaluate tissue inflammation in the kidney biopsies. Results: Patients with IgAN showed a significantly higher cellular density of JAK3 staining at the glomerular level compared to controls, indicating JAK3 activation (p < 0.0002). Nevertheless, the correlation between JAK3 positivity in glomeruli and clinical parameters such as the initial and final estimated glomerular filtration rate (eGFR) and proteinuria was not statistically significant. Identical results were obtained with CD68+ macrophage counts in the glomerular compartment, which did not show any correlation with clinical parameters, while CD68+ tubulointerstitial staining demonstrated a significant correlation with both initial (p = 0.002) and final eGFRs (p = 0.0014), proteinuria (p = 0.010), and interstitial fibrosis (p < 0.001), as well as with renal disease progression (p = 0.005). Conclusions: Patients with IgAN exhibited activation of the JAK/STAT pathway, in contrast to controls. Macrophage CD68 staining in the tubulointerstitial area increased and was associated with clinical and laboratory parameters such as eGFR and proteinuria. Additionally, MEST-C histological parameters, such as segmental glomerulosclerosis (S0/S1), tubular atrophy/interstitial fibrosis (T0/T1/T2), and crescents (C0/C1/C2), were associated with a higher number of CD68+ cells.
- 1 January 2026
- Published by MDPI AG in Preprints.org
Open AccessJAK3 Staining and CD68+ Macrophage Counts are Increased in Patients with IgA Nephropathy
Background/Objectives: IgA nephropathy (IgAN) is the most common primary glomerulopathy worldwide; it is characterized by a complex pathophysiology involving several inflammatory pathways. The Janus kinase/signal transducer and activator of transcription (JAK/STAT) pathway may be critical in this process. This study aimed to investigate the role of this pathway in IgAN and examine related tissue inflammatory markers. Methods: We analyzed 63 biopsy-confirmed patients with IgAN and performed immunohistochemical analysis on renal samples. A panel of antibodies targeting the JAK/STAT pathway, including JAK2, JAK3, p-STAT, STAT3, and MAPK/ERK, was used for this analysis. Six kidney tumor border samples were used as controls. Additionally, CD68 staining was used to evaluate tissue inflammation in the kidney biopsies. Results: Patients with IgAN showed a significantly higher cellular density of JAK3 staining at the glomerular level compared to controls, indicating JAK3 activation (p < 0.0002). Nevertheless, the correlation between JAK3 positivity in glomeruli and clinical parameters such as the initial and final estimated glomerular filtration rate (eGFR) and proteinuria was not statistically significant. Identical results were obtained with CD68+ macrophage counts in the glomerular compartment, which did not show any correlation with clinical parameters, while CD68+ tubulointerstitial staining demonstrated a significant correlation with both initial (p = 0.002) and final eGFRs (p = 0.0014), proteinuria (p = 0.010), and interstitial fibrosis (p < 0.001), as well as with renal disease progression (p = 0.005). Conclusions: Patients with IgAN exhibited activation of the JAK/STAT pathway, in contrast to controls. Macrophage CD68 staining in the tubulointerstitial area increased and was associated with clinical and laboratory parameters such as eGFR and proteinuria. Additionally, MEST-C histological parameters, such as segmental glomerulosclerosis (S0/S1), tubular atrophy/interstitial fibrosis (T0/T1/T2), and crescents (C0/C1/C2), were associated with a higher number of CD68+ cells.
- Open Access
- 11 August 2025
- Published by Elsevier in Kidney International Reports
- Vol. 10 (11) , 4101-4105
Dengue Infection as a Trigger for Collapsing Glomerulopathy in Patients With APOL1 High-Risk Genotype
- 11 August 2025
- Published by Elsevier in Kidney International Reports
- Vol. 10 (11) , 4101-4105
Open AccessDengue Infection as a Trigger for Collapsing Glomerulopathy in Patients With APOL1 High-Risk Genotype
- Open Access
- 29 April 2025
- Published by Elsevier in American Journal of Transplantation
- Vol. 25 (9) , 2017-2022
Post-transplantat recurrence of lipoprotein glomerulopathy: report of 4 cases and literature review
- 29 April 2025
- Published by Elsevier in American Journal of Transplantation
- Vol. 25 (9) , 2017-2022
Open AccessPost-transplantat recurrence of lipoprotein glomerulopathy: report of 4 cases and literature review
- Open Access
- 10 February 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (2) , e0312410
Implementation and first report of the Brazilian Kidney Biopsy Registry
Background: Kidney biopsy registries are valuable tools for guiding clinical practice and developing health policies. In 2021, the Brazilian Society of Nephrology (SBN) created the Brazilian Kidney Biopsy Registry (BKBR). This is the first BKBR report, presenting patient data from 2021. Methods: BKBR is a web-based platform hosted on the BSN website, which contains patient demographics, clinical data, frequency, and distribution of histologic diagnosis of Brazilian adult native kidney biopsies. Results: Of the 1012 cases registered in 2021, 954 cases were evaluated after excluding pediatric and kidney transplant cases. Twenty-one centers enrolled patients, with representation from all Brazilian regions. There was a slight predominance of females (52.6%), a mean age of 44.7 ± 16 years, and 13.6% of patients were >65 years old. The main indication for kidney biopsy was renal dysfunction (56%) and nephrotic syndrome (41.4%), respectively. At the time of the biopsy, 47.9% of the patients were hypertensive and 15.2% were diabetic. Although 66.2% of patients had eGFR ≤60ml/min/1.73m2 upon biopsy, the majority (60.2%) had mild interstitial fibrosis and tubular atrophy. The most frequent diagnosis in the BKBR was glomerular disease (74.8%). Lupus nephritis was the most frequent diagnosis of glomerular disease (22.6%), followed by IgA nephropathy (13%) and focal segmental glomerulosclerosis (12.2%). Conclusion: This is the first report of a Nationwide registry of kidney biopsies in Brazil. This data provides pivotal information about the kidney disease profile in this country with continental dimensions.
- 10 February 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (2) , e0312410
Open AccessImplementation and first report of the Brazilian Kidney Biopsy Registry
Background: Kidney biopsy registries are valuable tools for guiding clinical practice and developing health policies. In 2021, the Brazilian Society of Nephrology (SBN) created the Brazilian Kidney Biopsy Registry (BKBR). This is the first BKBR report, presenting patient data from 2021. Methods: BKBR is a web-based platform hosted on the BSN website, which contains patient demographics, clinical data, frequency, and distribution of histologic diagnosis of Brazilian adult native kidney biopsies. Results: Of the 1012 cases registered in 2021, 954 cases were evaluated after excluding pediatric and kidney transplant cases. Twenty-one centers enrolled patients, with representation from all Brazilian regions. There was a slight predominance of females (52.6%), a mean age of 44.7 ± 16 years, and 13.6% of patients were >65 years old. The main indication for kidney biopsy was renal dysfunction (56%) and nephrotic syndrome (41.4%), respectively. At the time of the biopsy, 47.9% of the patients were hypertensive and 15.2% were diabetic. Although 66.2% of patients had eGFR ≤60ml/min/1.73m2 upon biopsy, the majority (60.2%) had mild interstitial fibrosis and tubular atrophy. The most frequent diagnosis in the BKBR was glomerular disease (74.8%). Lupus nephritis was the most frequent diagnosis of glomerular disease (22.6%), followed by IgA nephropathy (13%) and focal segmental glomerulosclerosis (12.2%). Conclusion: This is the first report of a Nationwide registry of kidney biopsies in Brazil. This data provides pivotal information about the kidney disease profile in this country with continental dimensions.